A randomised controlled trial to evaluate the effectiveness of a bowel cancer screening decision aid for adults with low literacy

Not Applicable

Completed

• Conditions: Bowel cancer; Cancer - Bowel - Back passage (rectum) or large bowel (colon); Public Health - Other public health

• Registration Number: ACTRN12608000011381
• Lead Sponsor: Dr Kirsten McCaffery

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2008-01-10
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 600

Inclusion Criteria

Men and Women aged 55-64 years
Low levels of education (no formal educational qualifications, intermediate certificate (or equivalent), trade/apprenticeship (e.g. hairdresser, carpenter)
English as main language spoken at home
Average risk of bowel cancer (no family history or weak family history of bowel cancer)

Exclusion Criteria

Respondents who attained higher school or leaving certificate (or equivalent), TAFE certificate, diploma, University degree or higher will not be able to take part in the trial
Respondents who have invited to and or already taking part in the National Bowel Cancer Screening program
Respondents who have bowel cancer or had a bowel condition in the last 12 months which is currently under treatment
Respondents who have had a bowel cancer screening test in the last 2 years (this includes: faecal occult blood test, colonoscopy, flexible sigmoidoscopy)
Respondents with a strong family history of bowel cancer

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Informed decision making (attitudes towards bowel cancer screening, knowledge about screening and screening behaviour). This will be measured using a telephone survey.[Attitudes and understanding of bowel cancer screening will be measured 2-3 weeks after intervention commencement<br>Screening behaviour will be cross checked with the laboratory, 3 months after intervention commencement];Involvement preferences in screening decisions. This will be measured using a telephone survey.[2-3 weeks post intervention]